Essayer OR - Gratuit
Indian VCs join the race to back next big AI disruptor
Mint Mumbai
|February 24, 2025
The world may still be trying to gauge the scale of upheaval from generative AI.
Yet, Indian venture capital investors have joined top global peers in chasing the next disruptive offshoot of generative AI: agentic AI.
Agentic AI is a sophisticated algorithm that can adapt and learn on its own, building on the success of large language models like ChatGPT that need humans to train them. Built for a specific field, it resembles a worker skilled in a certain task—such as customer service, invoicing and more—and operates as a network of skilled professionals to automate tasks.
"Even though the technology is in nascent stages—closer to OpenAI's ChatGPT 3.0—the excitement around agentic systems is about the potential of completely automating repeatable tasks that were taking up a lot of effort," said Prayank Swaroop, partner at Accel, which has started investing in the technology.
Last week, decade-old health-tech firm Innovaccer debuted seven such agents to relieve overworked doctors and medical staff around the world. The San Francisco-based startup is now valued at around $3.5 billion, after raising funds from Facebook co-founder Eduardo Saverin's Singapore-based B Capital Group, and Microsoft's investing arm M12 participate.
Indian venture capital firms are also scouting for potential investment opportunities in some of the world's most promising agentic AI ventures in India and overseas.
Cette histoire est tirée de l'édition February 24, 2025 de Mint Mumbai.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint Mumbai
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

